Key result
COMPRESSION-HF tests if lower-limb compression boosts early natriuresis and weight loss in ADHF.
Why the study?
In ADHF with predominant interstitial fluid expansion but without intravascular overload, intensifying diuretics may cause intravascular depletion and renal worsening without clearing excess tissue fluid.
Does adding lower-limb compression to standard diuretic treatment improve early decongestion in patients with acute decompensated heart failure and predominant peripheral oedema?
RCT (n=106)
Double-blind
1:1
Yes
Does adding lower-limb compression to standard diuretic treatment improve early decongestion in patients with acute decompensated heart failure and predominant peripheral oedema?
The COMPRESSION-HF trial is designed to evaluate whether lower-limb compression enhances natriuresis and weight loss in acute heart failure patients with predominant tissue congestion.
Answers are grounded in this paper and cite their sources.
Tests mechanical compression as diuretic adjunct in ADHF with oedema; leaves open whether it augments early natriuresis and weight loss.
AIMS: . Acute decompensated heart failure (ADHF) is often treated with diuretic agents in both the inpatient and ambulatory settings, yet fluid overload frequently persists and is associated with rehospitalisation and death. In patients with predominant interstitial fluid expansion but without intravascular overload, increasing the loop-diuretic dose or adding a second diuretic may cause intravascular volume depletion, electrolyte disturbance, and worsening renal function without clearing the excess tissue fluid. COMPRESSION-HF tests whether adding lower-limb compression to standard diuretic treatment improves early decongestion in patients with ADHF, predominant peripheral oedema, and inferior vena cava diameter ≤21 mm. METHODS: . COMPRESSION-HF (NCT06418932) is an investigator-initiated, multicentre, randomised, double-blind, sham-controlled trial in which adults with ADHF, bilateral leg oedema (≥grade II/IV), NT-proBNP >1000 pg/mL, and inferior vena cava (IVC) diameter ≤21 mm were assigned 1:1 to active bilateral lower-limb compression (two-layer inelastic-elastic bandaging; manufacturer-specified nominal ankle pressure approximately 20 mmHg) plus parenteral furosemide or to sham bandaging plus parenteral furosemide, for up to 72 h. The two co-primary endpoints are 24-h urinary sodium excretion and change in body weight from baseline. Secondary endpoints include changes in lower-limb circumference, clinical congestion score, and IVC diameter, together with NT-proBNP at 72 h, cumulative 72-h furosemide-equivalent dose, CA-125 at day 15 ± 3, and 30-day safety. Continuous endpoints will be analysed with mixed-effects ANCOVA or repeated-measures models including centre as a random intercept. Recruitment is complete (106 patients randomised); the trial was powered to detect a 20 mmol between-group difference in 24-h urinary sodium excretion. CONCLUSIONS: COMPRESSION-HF will show whether adding lower-limb compression to standard loop-diuretic treatment increases natriuresis and weight loss in patients with ADHF and predominant peripheral oedema, and will describe the relationship between tissue congestion, intravascular refilling, and the diuretic response.
No takes yet. Share an insight, caveat, or question.
Civera et al. (2026) conducted an RCT in Acute decompensated heart failure (n=106). Bilateral lower-limb compression vs. Sham bandaging was evaluated on Change in body weight from baseline to 24 h and total urinary sodium excretion during the first 24 h. The COMPRESSION-HF trial will determine whether adding lower-limb compression to standard diuretic therapy improves early natriuresis and weight loss in patients with acute decompensated heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: